<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019efa38-be8f-7dd3-ab00-1418443716b4,g:75cc0028-267f-482c-a31f-8dea11247937-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="oncy-20260630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019efa38-bf5f-74af-99cb-530cb46e577f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019efa38-bf5f-7bf2-96da-7709af10db07" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019efa38-bf5f-74af-99cb-530cb46e577f" xlink:to="loc_us-gaap_LiabilitiesCurrent_019efa38-bf5f-7bf2-96da-7709af10db07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019efa38-bf5f-7617-980b-ca26e7fcd6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019efa38-bf5f-74af-99cb-530cb46e577f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019efa38-bf5f-7617-980b-ca26e7fcd6bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent_019efa38-bf5f-7199-91cd-0725c990cd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019efa38-bf5f-74af-99cb-530cb46e577f" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent_019efa38-bf5f-7199-91cd-0725c990cd0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019efa38-bf5f-7d20-9a44-028e5a50fb49" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019efa38-bf5f-74af-99cb-530cb46e577f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019efa38-bf5f-7d20-9a44-028e5a50fb49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019efa38-bf5f-7039-b9e1-4be74618b633" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019efa38-bf5f-7beb-84e4-6051bba20e90" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019efa38-bf5f-7039-b9e1-4be74618b633" xlink:to="loc_us-gaap_Liabilities_019efa38-bf5f-7beb-84e4-6051bba20e90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019efa38-bf5f-731d-8c9b-cf01eef689ec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019efa38-bf5f-7039-b9e1-4be74618b633" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019efa38-bf5f-731d-8c9b-cf01eef689ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019efa38-bf5f-7222-8db5-087adb9b188d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019efa38-bf5f-7039-b9e1-4be74618b633" xlink:to="loc_us-gaap_StockholdersEquity_019efa38-bf5f-7222-8db5-087adb9b188d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019efa38-bf5f-7398-b6ce-5142a325e987" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019efa38-bf5f-76a9-aa5e-ef6646fa01ca" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019efa38-bf5f-7398-b6ce-5142a325e987" xlink:to="loc_us-gaap_CommonStockValue_019efa38-bf5f-76a9-aa5e-ef6646fa01ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019efa38-bf5f-7bd8-9090-02a54472ada8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019efa38-bf5f-7398-b6ce-5142a325e987" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019efa38-bf5f-7bd8-9090-02a54472ada8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019efa38-bf5f-7745-809a-4ebb0305fa36" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019efa38-bf5f-7398-b6ce-5142a325e987" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019efa38-bf5f-7745-809a-4ebb0305fa36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019efa38-bf5f-753f-9f01-56e35cc5d9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019efa38-bf5f-7398-b6ce-5142a325e987" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019efa38-bf5f-753f-9f01-56e35cc5d9b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019efa38-bf5f-7635-be46-c3e345003558" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019efa38-bf5f-7c50-8bf7-6a7bc5693565" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019efa38-bf5f-7635-be46-c3e345003558" xlink:to="loc_us-gaap_AccountsPayableCurrent_019efa38-bf5f-7c50-8bf7-6a7bc5693565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019efa38-bf5f-7cf9-a054-639e8d9dd089" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019efa38-bf5f-7635-be46-c3e345003558" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019efa38-bf5f-7cf9-a054-639e8d9dd089" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019efa38-bf5f-769f-b7b1-9989dc3692e2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019efa38-bf5f-7635-be46-c3e345003558" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019efa38-bf5f-769f-b7b1-9989dc3692e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_019fa2bf-1384-7def-ba98-789ad94721c4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019efa38-bf5f-7635-be46-c3e345003558" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_019fa2bf-1384-7def-ba98-789ad94721c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019efa38-bf5f-71da-9847-5d76bb79c63e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019efa38-bf5f-7d5a-8a75-4971d13f8a62" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019efa38-bf5f-71da-9847-5d76bb79c63e" xlink:to="loc_us-gaap_AssetsCurrent_019efa38-bf5f-7d5a-8a75-4971d13f8a62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019efa38-bf5f-74f7-9bcf-34b883999bda" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019efa38-bf5f-71da-9847-5d76bb79c63e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019efa38-bf5f-74f7-9bcf-34b883999bda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019efa38-bf5f-7291-b3ef-346d7649fbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019efa38-bf5f-71da-9847-5d76bb79c63e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019efa38-bf5f-7291-b3ef-346d7649fbfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019efa38-bf5f-7ec4-bf96-859b459b556f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019efa38-bf5f-75fa-8f42-bd86f3088a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019efa38-bf5f-7ec4-bf96-859b459b556f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019efa38-bf5f-75fa-8f42-bd86f3088a9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_019efa38-bf5f-744e-9af5-a9eff0792786" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019efa38-bf5f-7ec4-bf96-859b459b556f" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_019efa38-bf5f-744e-9af5-a9eff0792786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_019efa38-bf5f-737f-be07-416e1ca481d6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019efa38-bf5f-7ec4-bf96-859b459b556f" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_019efa38-bf5f-737f-be07-416e1ca481d6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSunaudited" xlink:type="simple" xlink:href="oncy-20260630.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSunaudited"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019fa2d1-2633-712b-a36d-b5437770ce8d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019fa2d1-2633-74b6-9294-2fd1e2533f92" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019fa2d1-2633-712b-a36d-b5437770ce8d" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019fa2d1-2633-74b6-9294-2fd1e2533f92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_019fa2d1-2633-7ebb-85fe-a0fe62f20524" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019fa2d1-2633-712b-a36d-b5437770ce8d" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_019fa2d1-2633-7ebb-85fe-a0fe62f20524" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_019fa2d1-2633-76f5-8690-98b6413ea128" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019fa2d1-2633-712b-a36d-b5437770ce8d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_019fa2d1-2633-76f5-8690-98b6413ea128" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019fa2d1-2633-7279-8f2e-7c5d31e4710d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019fa2d1-2633-712b-a36d-b5437770ce8d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019fa2d1-2633-7279-8f2e-7c5d31e4710d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019fa2cb-2fab-78ca-9e4e-bde5e3383a94" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019fa2cb-2fab-76c7-9ee3-c91ee1b9ad25" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019fa2cb-2fab-78ca-9e4e-bde5e3383a94" xlink:to="loc_us-gaap_OperatingExpenses_019fa2cb-2fab-76c7-9ee3-c91ee1b9ad25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019fa2cb-2fab-78d6-87b6-7248885b3831" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019fa2cb-2fab-7ac5-bdb0-c49b365b6238" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019fa2cb-2fab-78d6-87b6-7248885b3831" xlink:to="loc_us-gaap_NetIncomeLoss_019fa2cb-2fab-7ac5-bdb0-c49b365b6238" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019fa2cb-2fab-7612-a618-b9d0e8e92e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019fa2cb-2fab-78d6-87b6-7248885b3831" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019fa2cb-2fab-7612-a618-b9d0e8e92e4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019fa2cb-2fab-7c20-85ea-ce114ccb4a54" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019fa2cb-2fab-7e57-b5f7-7303c98f1daf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019fa2cb-2fab-7c20-85ea-ce114ccb4a54" xlink:to="loc_us-gaap_OperatingIncomeLoss_019fa2cb-2fab-7e57-b5f7-7303c98f1daf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019fa2cb-2fab-7472-9669-f938624c960f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019fa2cb-2fab-7c20-85ea-ce114ccb4a54" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019fa2cb-2fab-7472-9669-f938624c960f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019fa2cb-2fab-79ca-b584-48d6cf9ff00f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019fa2cb-2fab-78b9-8856-135c2e83c29f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019fa2cb-2fab-79ca-b584-48d6cf9ff00f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019fa2cb-2fab-78b9-8856-135c2e83c29f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019fa2cb-2fab-79ab-b7bd-84bee815f8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019fa2cb-2fab-79ca-b584-48d6cf9ff00f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019fa2cb-2fab-79ab-b7bd-84bee815f8d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019fa2cb-2fab-7cbb-92ff-a5aa8bfb65bc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019fa2cb-2fab-7630-b0ca-2f738262908a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019fa2cb-2fab-7cbb-92ff-a5aa8bfb65bc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019fa2cb-2fab-7630-b0ca-2f738262908a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019fa2cb-2fab-7ceb-9066-e810715f1d17" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019fa2cb-2fab-7cbb-92ff-a5aa8bfb65bc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019fa2cb-2fab-7ceb-9066-e810715f1d17" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="simple" xlink:href="oncy-20260630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fa2eb-351c-7ac9-b0f6-59327f3f3d91" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019fa2eb-351c-7aa2-9518-c18f48a1317f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fa2eb-351c-7ac9-b0f6-59327f3f3d91" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019fa2eb-351c-7aa2-9518-c18f48a1317f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019fa2eb-351c-7c81-a929-a1819f8ee05b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-75fa-a26e-9a9c857b6ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019fa2eb-351c-7c81-a929-a1819f8ee05b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-75fa-a26e-9a9c857b6ce2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fa2eb-351c-7cc8-8e6d-8196686b4d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019fa2eb-351c-7c81-a929-a1819f8ee05b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fa2eb-351c-7cc8-8e6d-8196686b4d4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fa2eb-351c-7771-931a-3eb30347212b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019fa2eb-351c-7c81-a929-a1819f8ee05b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fa2eb-351c-7771-931a-3eb30347212b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019fa2eb-351c-7a67-8df2-a8a96fec77b4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019fa2eb-351c-7c81-a929-a1819f8ee05b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019fa2eb-351c-7a67-8df2-a8a96fec77b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019fa2eb-351c-7e5e-8227-ef7c6507f4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_NetIncomeLoss_019fa2eb-351c-7e5e-8227-ef7c6507f4e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019fa2eb-351c-735f-b275-b39d4ea00ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_Depreciation_019fa2eb-351c-735f-b275-b39d4ea00ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_NoncashLeaseExpense_019fa2eb-351c-714f-b397-7bc76c8c3ab9" xlink:href="oncy-20260630.xsd#oncy_NoncashLeaseExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_oncy_NoncashLeaseExpense_019fa2eb-351c-714f-b397-7bc76c8c3ab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019fa2eb-351c-70df-b4c6-bcc07f9d1d55" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_ShareBasedCompensation_019fa2eb-351c-70df-b4c6-bcc07f9d1d55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019fa2eb-351c-7fac-a3ae-de4f36b6961f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019fa2eb-351c-7fac-a3ae-de4f36b6961f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_019fa2eb-351c-76e9-baa8-71213151a1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_019fa2eb-351c-76e9-baa8-71213151a1c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019fa2eb-351c-7cdc-bc34-cd6fe3573ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019fa2eb-351c-7cdc-bc34-cd6fe3573ac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_019fa2eb-351c-7ad8-b781-d3762ea22124" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_019fa2eb-351c-7ad8-b781-d3762ea22124" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_IssuanceOfStockForCommitmentFees_019fa2eb-351c-756e-a094-c888796c2464" xlink:href="oncy-20260630.xsd#oncy_IssuanceOfStockForCommitmentFees"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_oncy_IssuanceOfStockForCommitmentFees_019fa2eb-351c-756e-a094-c888796c2464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_019fa2eb-351c-7f15-b9c8-cca11baa41b3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_019fa2eb-351c-7f15-b9c8-cca11baa41b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_019fa2eb-351c-7f4b-958d-c895716ec4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_019fa2eb-351c-7f4b-958d-c895716ec4ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019fa2eb-351c-7af7-9c35-89666c6883c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019fa2eb-351c-7af7-9c35-89666c6883c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019fa2eb-351c-7278-9031-f3d0ef83988b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019fa2eb-351c-7278-9031-f3d0ef83988b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019fa2eb-351c-71a8-93ca-00cab9c9e209" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fa2eb-351c-7911-a571-694f5871295a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019fa2eb-351c-71a8-93ca-00cab9c9e209" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fa2eb-351c-753e-ba00-31bdc86c73a5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019fa2eb-351c-7d53-bd2d-d0db66745b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fa2eb-351c-753e-ba00-31bdc86c73a5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019fa2eb-351c-7d53-bd2d-d0db66745b8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesDetails" xlink:type="simple" xlink:href="oncy-20260630.xsd#BalanceSheetDetailsScheduleofPrepaidExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_019efa38-bf5f-7b6c-949c-6ad76c96fd70" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_PrepaidResearchAndDevelopment_019efa38-bf5f-7a21-bd91-c20100563b19" xlink:href="oncy-20260630.xsd#oncy_PrepaidResearchAndDevelopment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019efa38-bf5f-7b6c-949c-6ad76c96fd70" xlink:to="loc_oncy_PrepaidResearchAndDevelopment_019efa38-bf5f-7a21-bd91-c20100563b19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_019efa38-bf5f-7f95-9a03-b6a486e6c467" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019efa38-bf5f-7b6c-949c-6ad76c96fd70" xlink:to="loc_us-gaap_PrepaidInsurance_019efa38-bf5f-7f95-9a03-b6a486e6c467" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_PrepaidProfessionalFees_019efa38-bf5f-755f-91c3-2ad74eacfd8a" xlink:href="oncy-20260630.xsd#oncy_PrepaidProfessionalFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019efa38-bf5f-7b6c-949c-6ad76c96fd70" xlink:to="loc_oncy_PrepaidProfessionalFees_019efa38-bf5f-755f-91c3-2ad74eacfd8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_019efa38-bf5f-7aac-a4e5-197f5381b2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019efa38-bf5f-7b6c-949c-6ad76c96fd70" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_019efa38-bf5f-7aac-a4e5-197f5381b2aa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/BalanceSheetDetailsScheduleofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="oncy-20260630.xsd#BalanceSheetDetailsScheduleofAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/BalanceSheetDetailsScheduleofAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019efa38-bf5f-760b-8e8c-6ebaa0c6f956" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_AccruedResearchAndDevelopmentCurrent_019efa38-bf5f-7481-8939-3525b41e101a" xlink:href="oncy-20260630.xsd#oncy_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019efa38-bf5f-760b-8e8c-6ebaa0c6f956" xlink:to="loc_oncy_AccruedResearchAndDevelopmentCurrent_019efa38-bf5f-7481-8939-3525b41e101a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019efa38-bf5f-7317-bbfd-e293a48d1be7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019efa38-bf5f-760b-8e8c-6ebaa0c6f956" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019efa38-bf5f-7317-bbfd-e293a48d1be7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019efa38-bf5f-721a-8838-6ee5c7caee03" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019efa38-bf5f-760b-8e8c-6ebaa0c6f956" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019efa38-bf5f-721a-8838-6ee5c7caee03" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="oncy-20260630.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019efa38-bf5f-79bb-a057-c9a9296f080f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019efa38-bf5f-74f8-a1ce-73eed97cc13b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019efa38-bf5f-79bb-a057-c9a9296f080f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019efa38-bf5f-74f8-a1ce-73eed97cc13b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019efa38-bf5f-73ed-bb4c-dcb9c837ad75" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019efa38-bf5f-79bb-a057-c9a9296f080f" xlink:to="loc_us-gaap_OperatingLeaseLiability_019efa38-bf5f-73ed-bb4c-dcb9c837ad75" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="oncy-20260630.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019efa38-bf5f-77fc-b633-bb1a35c841b3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019efa38-bf5f-73a6-a7db-f3d4f08aeaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019efa38-bf5f-77fc-b633-bb1a35c841b3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019efa38-bf5f-73a6-a7db-f3d4f08aeaa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019efa38-bf5f-7bee-90d3-6da2bb0ca786" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019efa38-bf5f-77fc-b633-bb1a35c841b3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019efa38-bf5f-7bee-90d3-6da2bb0ca786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019efa38-bf5f-7b86-a22a-5e61ea52d713" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019efa38-bf5f-77fc-b633-bb1a35c841b3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019efa38-bf5f-7b86-a22a-5e61ea52d713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019efa38-bf5f-7309-8a20-2d974615d39e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019efa38-bf5f-77fc-b633-bb1a35c841b3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019efa38-bf5f-7309-8a20-2d974615d39e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.oncolyticsbiotech.com/role/SegmentInformationScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="oncy-20260630.xsd#SegmentInformationScheduleofSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.oncolyticsbiotech.com/role/SegmentInformationScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019efa38-bf60-7003-8444-cfea16197c34" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_ResearchAndDevelopmentExpenseClinicalTrial_019efa38-bf60-7e69-a099-ae87a93accfd" xlink:href="oncy-20260630.xsd#oncy_ResearchAndDevelopmentExpenseClinicalTrial"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019efa38-bf60-7003-8444-cfea16197c34" xlink:to="loc_oncy_ResearchAndDevelopmentExpenseClinicalTrial_019efa38-bf60-7e69-a099-ae87a93accfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_ResearchAndDevelopmentExpenseManufacturingAndRelatedProcessDevelopment_019efa38-bf60-745c-98d5-361439e87217" xlink:href="oncy-20260630.xsd#oncy_ResearchAndDevelopmentExpenseManufacturingAndRelatedProcessDevelopment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019efa38-bf60-7003-8444-cfea16197c34" xlink:to="loc_oncy_ResearchAndDevelopmentExpenseManufacturingAndRelatedProcessDevelopment_019efa38-bf60-745c-98d5-361439e87217" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019efa38-bf60-7752-b740-d44f823d7bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019efa38-bf60-7003-8444-cfea16197c34" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019efa38-bf60-7752-b740-d44f823d7bf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_019efa38-bf60-78e8-bac1-37dfb9c8ebd2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019efa38-bf60-7003-8444-cfea16197c34" xlink:to="loc_us-gaap_ProfessionalFees_019efa38-bf60-78e8-bac1-37dfb9c8ebd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalariesWagesAndOfficersCompensation_019efa38-bf60-74bc-abb9-4065baceb8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SalariesWagesAndOfficersCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019efa38-bf60-7003-8444-cfea16197c34" xlink:to="loc_us-gaap_SalariesWagesAndOfficersCompensation_019efa38-bf60-74bc-abb9-4065baceb8f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_IntellectualPropertyExpense_019efa38-bf60-71bd-8817-309a6bb13a0e" xlink:href="oncy-20260630.xsd#oncy_IntellectualPropertyExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019efa38-bf60-7003-8444-cfea16197c34" xlink:to="loc_oncy_IntellectualPropertyExpense_019efa38-bf60-71bd-8817-309a6bb13a0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_oncy_OtherResearchAndDevelopmentExpenseAndOtherGeneralAndAdministrativeExpense_019efa38-bf60-7e83-ae45-148fd56e6ed0" xlink:href="oncy-20260630.xsd#oncy_OtherResearchAndDevelopmentExpenseAndOtherGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019efa38-bf60-7003-8444-cfea16197c34" xlink:to="loc_oncy_OtherResearchAndDevelopmentExpenseAndOtherGeneralAndAdministrativeExpense_019efa38-bf60-7e83-ae45-148fd56e6ed0" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
